Online Course: Pharma-Biotech Product & Company Valuation by Dr. Patrik Frei
Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.
Why You Should Attend
Valuation is an inherently subjective task which is made even more difficult in the life science industry due its unique challenges: high attrition rates in R&D, long investment cycle, complex technologies and IP situations, etc. Therefore, traditional valuation methods are not suitable.
The Content: This course is designed to teach you a systematic approach to producing a valuation which can be used in investment rounds, mergers/acquisitions, licensing deals or strategic development decisions in the pharma-biotech world. It goes beyond the number-crunching techniques of most consultants and includes difficult to define qualitative factors which shape the risk profile of the company in question.
The Expert: Patrik Frei is leading expert in the valuation of life science companies, with vast sector-specific knowledge and experience, which allows him to speak with authority on the subject. Patrik wrote the first book on the valuation of high-growth companies and holds a Ph.D in the field. He founded Venture Valuation in 1999, which has remained true to its mission since then: the independent assessment and valuation of companies, products and patents in fast growing markets and industries including pharmaceuticals, Biotechnology and Medical Technology.
The Pharma-Biotech Product & Company Valuation - An Introductory Course is the only available public training course delivered by Patrik Frei on the topic of Valuation.